MedPath

Evaluation of Peri-surgical Results at Short and Mean Terms of the GORE ® Excluder Iliac Branch Endoprosthesis

Not Applicable
Terminated
Conditions
Iliac Aneurysm
Interventions
Device: ILIAC ENDOPROSTHESIS GORE EXCLUDER
Registration Number
NCT03312127
Lead Sponsor
University Hospital, Toulouse
Brief Summary

The aim of this project is to demonstrate the benefit of the use of aortic iliac branch endoprosthesis in the iliac aneurysms and to avoid the classic complications.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
3
Inclusion Criteria
  • High surgical risk:

    • Comorbidity cardiopulmonary
    • Renal insufficiency
    • Hostile abdomen including ascites or portal hypertension
  • Anatomic criteria:

    • Primitive iliac aneurysm superior to 25 mm without collar
    • Primitive iliac length superior to 40 mm
    • Primitive iliac distal diameter superior to 14 mm
    • Presence of internal iliac collar
  • Affiliation to a social security system

Exclusion Criteria
  • Patient without surgical risk
  • Non-respect of the Anatomic criteria
  • Patient with known allergy to the materials of the device
  • Patient with systemic infection
  • Patient with severe renal insufficiency
  • Patient unable to complete the oximetry test
  • Persons under legal protection

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
GORE ExcluderILIAC ENDOPROSTHESIS GORE EXCLUDERGORE Excluder Iliac Branch Endoprosthesis arm with 'ILIAC ENDOPROSTHESIS GORE EXCLUDER'
Primary Outcome Measures
NameTimeMethod
Primary permeability maintenance of the iliac branch endoprosthesis, following its insertion (binary criterion)at 12 months after surgery

Primary permeability maintenance of the iliac branch endoprosthesis, following its insertion. It is a binary criterion (permeable or not) This criterion will be evaluated by a doppler ultrasound. These exams will be performed by a unique vascular physician, who will measure the hemodynamic criterions and the associated gluteal region oximetry.

Endoprosthesis will be considered to be permeable if the patient is asymptomatic (absence of gluteal claudication), if Doppler ultrasound and angio-scan confirm the permeability of the endoprosthesis.

Primary permeability will be considered non-maintained at 1 year if a stenosis \>70% or a thrombosis of the hypogastric branch is observed by ultra-sound scan at a follow-up visit during the first year after surgery or at a ultra-sound scan exam motivated by pelvic ischemia clinical signs

Secondary Outcome Measures
NameTimeMethod
Morbidityperi-operative, at short term (3 months), mean-term (12 months)

Evaluation of the morbidity:

* Minor events (no revision surgery needed):

* General: pulmonary, cardiologic, renal

* Local: hematoma, false aneurysm, Impaired wound healing

* Major events (revision surgery needed):

* Endoleak

* Thrombosis

* Rupture

Trial Locations

Locations (1)

University Hospital Toulouse

🇫🇷

Toulouse, France

© Copyright 2025. All Rights Reserved by MedPath